Developing products and services, including digitalization, private-pay revenue and preventive-care programs

「本新株式の発行価額の総額（43,300,000 円）及び本新株予約権の発行価額の総額（891,000 円）の払込が完了したことを確認いたしました」

「Through the capital and business alliance, the company will add AI and DX reskilling training as a precursor to AI consulting and establish a delivery structure combining the training with SaaS for managing participants’ goals and progress.」

「Various consulting services are recurring consulting services generally provided under contracts with fixed periods, such as annual contracts. They address management and operational challenges at osteopathic clinics, including improving business performance, improving financial conditions, developing organizational structures, and developing personnel and using knowledge through AI.」

「In software, we sell systems for osteopathic clinics. Revenue totaled ¥113,919 thousand, down 11.1% from the same interim period of the previous year, reflecting the impact of the previous year’s transfer of the Ligoo POS & CRM and Rese ONE businesses.」

「Until now, the Company had handled system development, maintenance and functional improvements, system sales, and operational support. However, to adapt to advanced development technologies and future changes in the development environment, we concluded that system development, maintenance and functional improvements should be handled by a company with strong development capabilities, while we focus on our strengths in system sales and operational support.」

「We sold Rese ONE Plus, which combines Ligoo POS & CRM and Rese ONE, along with maintenance services and systems sold by 日本ソフトウエア販売株式会社. As the number of new Rese ONE Plus sales declined from the previous fiscal year, revenue totaled ¥313,498 thousand, down 11.6% year on year.」

「Software revenue totaled ¥221,449 thousand, up 10.3% year on year, from sales and maintenance fees for Rese ONE Plus, which combines Ligoo POS & CRM and Rese ONE, and system sales by 日本ソフトウエア販売株式会社.」

「Sales of our IFMC.-based healthcare brands Dr.Supporter and My.Supporter remained solid, with many repeat orders. Revenue totaled ¥151,771 thousand, up 1,181.7% year on year, due in part to sales of “environmental turf” treated with IFMC., which 株式会社IFMC. handled as its exclusive distributor. Products and services using IFMC. technology had previously been included in equipment and consumables, but from the first quarter of the current consolidated fiscal year they were classified separately as health support, and the comparative figures have been restated accordingly.」

「We began selling Rese ONE in February 2019, and the number of clinics using it was 1,204 as of the end of March 2023. We have also sold Rese ONE Plus, which combines the functions of CRM and Rese ONE, since June 2020. Through CRM data integration, an osteopathic clinic can use CRM’s analytical functions simply by entering claims information.」

「Software revenue totaled ¥354,556 thousand, up 11.7% year on year, mainly because sales of Rese ONE Plus remained solid and sales by 日本ソフトウエア販売株式会社 contributed.」

「Based on a resolution of the Board of Directors meeting held on 13 September 2022, the Company established a subsidiary, 株式会社ＩＦＭＣ． (3) Business: Development of IFMC., promotional activities, and management of distributors (4) Capital: ¥10,000 thousand (5) Date established: 4 October 2022 (6) Ownership: Company 70%; 株式会社テイコク製薬社 30%」

「Software revenue totaled ¥109,214 thousand, up 42.8% year on year, due to sales of Rese ONE Plus, which combines Ligoo POS & CRM and Rese ONE, and sales contributed by 日本ソフトウエア販売株式会社.」

「We began selling Rese ONE in February 2019, and the number of clinics using it was 757 as of the end of March 2022. A key feature is that, through data integration with CRM, an osteopathic clinic can use CRM’s analytical functions simply by entering claims information.」

「We began selling the healthcare brand “Dr.Supporter” in June 2021. Cost of sales and selling, general and administrative expenses each increased due to sampling, advertising to raise product awareness, active recruitment of sales personnel, and depreciation recorded for additional functions added to the core software “Rese ONE.”」

「In equipment and consumables, we sold equipment supporting the expansion of self-pay treatment menus at osteopathic clinics. Sales of Dr.Supporter resulted in revenue of ¥578,162 thousand, up 133.3% year on year.」

「In equipment and consumables, although we refrained from face-to-face sales activities under the state of emergency declared due to the spread of COVID-19, we sold equipment supporting the expansion of self-pay treatment menus at osteopathic clinics and educational materials compiling our consulting expertise. Sales of the healthcare brand “Dr.Supporter,” treated with IFMC. ingredients and expected to improve fatigue and relieve muscle fatigue and stiffness by promoting blood circulation, resulted in revenue of ¥221,847 thousand, up 164.2% year on year.」

「In equipment and consumables, we sold equipment used to support the expansion of self-pay treatment menus at osteopathic clinics, educational materials compiling our consulting expertise, and IFMC. products as new merchandise from March 2021.」

「In software, we sold the patient information management system for osteopathic clinics “Ligoo POS & CRM” and the claims-calculation system “Rese ONE.” Revenue totaled ¥431,843 thousand, up 68.6% year on year, mainly because we provided Rese ONE to business partners and began selling Rese ONE Plus, which combines Rese ONE and Ligoo POS & CRM, in June 2020.」

「In software, we sold the patient information management system for osteopathic clinics “Ligoo POS & CRM” and the claims-calculation system “Rese ONE.” Revenue totaled ¥324,518 thousand, mainly because we provided Rese ONE to business partners and began selling Rese ONE Plus, which combines Rese ONE and Ligoo POS & CRM, in June 2020.」

「Revenue totaled ¥252,348 thousand, mainly because we provided “Rese ONE” to business partners and began selling “Rese ONE Plus,” which combines “Rese ONE” and “Ligoo POS & CRM,” in June 2020.」

「We consider improving productivity through digitalization, building management structures for osteopathic clinics that do not rely excessively on treatment reimbursements, and developing preventive-care programs for clinic users, such as training aimed at improving health, to be common challenges for the osteopathic clinic industry. We will continue to develop new products and services.」